Eli Lilly and Company
(NYSE : LLY)

( )
LLY PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
1.59%42.080.9%$926.18m
JNJJohnson & Johnson
1.51%134.480.6%$813.44m
ABBVAbbVie, Inc.
0.59%98.802.1%$739.09m
MRKMerck & Co., Inc.
0.29%69.050.6%$615.33m
LLYEli Lilly and Company
1.13%105.541.0%$482.15m
BMYBristol-Myers Squibb Company
-0.34%60.901.4%$400.65m
AZNAstraZeneca PLC Sponsored ADR
0.45%38.131.3%$173.57m
NVSNovartis AG Sponsored ADR
1.07%83.070.2%$156.34m
GSKGlaxoSmithKline plc Sponsored ADR
1.02%41.250.2%$131.34m
SNYSanofi Sponsored ADR
1.96%42.060.2%$95.07m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.69%47.440.1%$71.10m
LCILannett Company, Inc.
-1.82%13.5037.9%$7.22m
AKTXAkari Therapeutics Plc Sponsored ADR
2.20%1.861.7%$0.04m
EPIXESSA Pharma Inc
-1.61%3.050.0%$0.02m

Company Profile

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. It operates through two segments: Human Pharmaceutical Products and Animal Health. The Human Pharmaceutical products segment includes the discovery, development, manufacturing, marketing and sales of human pharmaceutical products worldwide in the following therapeutic areas: neuroscience, endocrinology, oncology, cardiovascular and other. The Animal health segment operating through the Elanco Animal Health division, develops, manufactures, and markets products for both food and companion animals. The Animal health products include Rumensin, Tylan, Posilac, Paylean and other products for livestock and poultry, as well as Trifexis, Comfortis, and other products for companion animals. The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.